{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:23:51Z","timestamp":1792686231414,"version":"4.5.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"\n Importance<\/jats:title>\n In patients with atrial fibrillation (AF), oral anticoagulation (OAC) is the gold standard for preventing ischemic stroke, at the expense of a higher risk of bleeding. Catheter-based left atrial appendage closure (LAAC) has been proposed as an alternative strategy to prevent stroke, but the efficacy and safety compared to OAC are uncertain.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the efficacy and safety of catheter-based LAAC compared to OAC in patients with AF at high risk of stroke.<\/jats:p>\n <\/jats:sec>\n \n Data Sources<\/jats:title>\n PubMed, Cochrane Central, and Web of Science were screened up to March 2026. The websites of leading cardiology societies, news outlets, and reference lists of each eligible study were also inspected.<\/jats:p>\n <\/jats:sec>\n \n Study Selection<\/jats:title>\n Studies enrolling patients with AF randomly assigned to catheter-based LAAC or OAC and reporting at least 1 outcome of interest were included.<\/jats:p>\n <\/jats:sec>\n \n Data Extraction and Synthesis<\/jats:title>\n Two investigators independently extracted data of interest and assessed data quality. Catheter-based LAAC vs OAC comparisons were pooled as incidence rate ratios (IRRs) using a frequentist random-effect model.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Primary and coprimary outcomes were long-term stroke and major bleeding. Secondary outcomes included the composite of cardiovascular death, stroke, or systemic embolism, all-cause death, the single components of the composite end point, ischemic stroke, hemorrhagic stroke, and nonprocedural major bleeding. Periprocedural events (ie, stroke, major bleeding, death, device embolization, and pericardial effusion) were also combined.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Eight trials (7434 patients) were included in the meta-analysis. After a weighted mean follow-up of 37.9 months, no significant differences were detected for stroke (IRR, 1.08; 95% CI, 0.82-1.41) and major bleeding (IRR, 0.96; 95% CI, 0.81-1.14). However, catheter-based LAAC was associated with a higher risk of ischemic stroke (IRR, 1.34; 95% CI, 1.01-1.77) and a lower risk of nonprocedural major bleeding (IRR, 0.73; 95% CI, 0.58-0.92) compared with OAC. Periprocedural events per 1000 patients were 5 strokes, 9 episodes of bleeding, 1 death, 5 episodes of device embolization, and 9 pericardial effusions.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In patients with AF, at long-term follow-up, transcatheter LAAC was associated with similar rates of any type of stroke and major bleeding compared with OAC, while increasing the risk of ischemic stroke and lowering the risk of nonprocedure-related major bleeding. These findings do not support the routine use of LAAC as a first-line strategy for stroke prevention in patients with AF at moderate to high risk of stroke.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamacardio.2026.2640","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:30:30Z","timestamp":1787758230000},"page":"915","source":"Crossref","is-referenced-by-count":2,"title":["Catheter-Based Left Atrial Appendage Closure vs Oral Anticoagulation in Patients With Atrial Fibrillation"],"prefix":"10.1001","volume":"11","author":[{"given":"Claudio","family":"Laudani","sequence":"first","affiliation":[{"name":"Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico Rodolico \u2013 San Marco, University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Bujak","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico Rodolico \u2013 San Marco, University of Catania, Catania, Italy"},{"name":"Department of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland"},{"name":"3rd Department of Cardiology, Silesian Center for Heart Diseases, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Giacoppo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico Rodolico \u2013 San Marco, University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Finocchiaro","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico Rodolico \u2013 San Marco, University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Cutore","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico Rodolico \u2013 San Marco, University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sara","family":"Mauro","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico Rodolico \u2013 San Marco, University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Redigolo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico Rodolico \u2013 San Marco, University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Placido Maria","family":"Mazzone","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico Rodolico \u2013 San Marco, University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacinto","family":"Di Leo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico Rodolico \u2013 San Marco, University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Nasisi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico Rodolico \u2013 San Marco, University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Spagnolo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico Rodolico \u2013 San Marco, University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Greco","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico Rodolico \u2013 San Marco, University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Capodanno","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico Rodolico \u2013 San Marco, University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"hoi260039r1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-022-00347-9","article-title":"Atrial fibrillation.","volume":"8","author":"Brundel","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"hoi260039r2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1212\/WNL.28.10.973","article-title":"Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study.","volume":"28","author":"Wolf","year":"1978","journal-title":"Neurology"},{"issue":"10","key":"hoi260039r3","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1253\/circj.CJ-12-1036","article-title":"Stroke and thromboembolism in atrial fibrillation.","volume":"76","author":"Pisters","year":"2012","journal-title":"Circ J"},{"issue":"9921","key":"hoi260039r4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"8631","key":"hoi260039r5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebu: the Copenhagen AFASAK study.","volume":"333","author":"Petersen","year":"1989","journal-title":"Lancet"},{"issue":"36","key":"hoi260039r6","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"1","key":"hoi260039r7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"4","key":"hoi260039r8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034778","article-title":"Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies.","volume":"10","author":"Salmasi","year":"2020","journal-title":"BMJ Open"},{"issue":"2","key":"hoi260039r9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-090541","article-title":"Contemporary European practice in left atrial appendage closure: results from a survey focusing on planning, techniques and post-implantation management.","volume":"15","author":"Garot","year":"2025","journal-title":"BMJ Open"},{"issue":"13","key":"hoi260039r10","doi-asserted-by":"publisher","first-page":"e1038","DOI":"10.4244\/EIJ-D-22-00627","article-title":"Left atrial appendage occlusion.","volume":"18","author":"Holmes","year":"2023","journal-title":"EuroIntervention"},{"issue":"13","key":"hoi260039r11","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1056\/NEJMoa2513310","article-title":"Left atrial appendage closure or medical therapy in atrial fibrillation.","volume":"394","author":"Landmesser","year":"2026","journal-title":"N Engl J Med"},{"issue":"21","key":"hoi260039r12","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa2517213","article-title":"Left atrial appendage closure or anticoagulation for atrial fibrillation.","volume":"394","author":"Doshi","year":"2026","journal-title":"N Engl J Med"},{"issue":"71","key":"hoi260039r13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"hoi260039r15","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"hoi260039r16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. making an overall rating of confidence in effect estimates for a single outcome and for all outcomes.","volume":"66","author":"Guyatt","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"hoi260039r17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"hoi260039r18","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"issue":"25","key":"hoi260039r19","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation.","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"hoi260039r20","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left atrial appendage closure after ablation for atrial fibrillation.","volume":"392","author":"Wazni","year":"2025","journal-title":"N Engl J Med"},{"issue":"12","key":"hoi260039r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.shj.2025.100735","article-title":"Left atrial appendage occlusion using the Amplatzer Amulet device in high-risk patients with atrial fibrillation undergoing transcatheter aortic valve intervention: a randomized pilot study.","volume":"9","author":"Jakob","year":"2025","journal-title":"Struct Heart"},{"issue":"10","key":"hoi260039r22","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1161\/CIRCULATIONAHA.123.067312","article-title":"Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation.","volume":"149","author":"Kapadia","year":"2024","journal-title":"Circulation"},{"issue":"10513","key":"hoi260039r23","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","article-title":"Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.","volume":"406","author":"GBD 2023 Causes of Death Collaborators","year":"2025","journal-title":"Lancet"},{"issue":"9","key":"hoi260039r24","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1161\/CIR.0000000000001412","article-title":"2026 Heart disease and stroke statistics: a report of US and global data from the American Heart Association.","volume":"153","author":"Palaniappan","year":"2026","journal-title":"Circulation"},{"issue":"2","key":"hoi260039r25","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.003074","article-title":"Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation.","volume":"5","author":"Yao","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"hoi260039r26","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"issue":"24","key":"hoi260039r27","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials.","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hoi260039r28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/europace\/euac130","article-title":"The association of coagulation and atrial fibrillation: a systematic review and meta-analysis.","volume":"25","author":"Tilly","year":"2023","journal-title":"Europace"},{"issue":"3","key":"hoi260039r29","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1161\/STROKEAHA.115.012004","article-title":"Atrial fibrillation and mechanisms of stroke: time for a new model.","volume":"47","author":"Kamel","year":"2016","journal-title":"Stroke"},{"issue":"14","key":"hoi260039r30","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","article-title":"Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation.","volume":"71","author":"Fauchier","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"hoi260039r31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005997","article-title":"Device thrombosis after percutaneous left atrial appendage occlusion is related to patient and procedural characteristics but not to duration of postimplantation dual antiplatelet therapy.","volume":"11","author":"Pracon","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"hoi260039r32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/jme-2023-109301","article-title":"What makes a medical intervention invasive?","volume":"50","author":"De Marco","year":"2024","journal-title":"J Med Ethics"},{"issue":"10","key":"hoi260039r33","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1001\/jamacardio.2024.2335","article-title":"Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: the ADALA randomized clinical trial.","volume":"9","author":"Freixa","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"7","key":"hoi260039r34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.101021","article-title":"Assessment of noninferiority margins in cardiovascular medicine trials.","volume":"3","author":"Greco","year":"2024","journal-title":"JACC Adv"},{"key":"hoi260039r14","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4","author":"Higgins","year":"2023"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2853336\/jamacardiology_laudani_2026_oi_260039_1790870214.2805.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:00:55Z","timestamp":1791990055000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2853336"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2026.2640","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}